Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Diseases

Free Subscription 18.03.2019 1 AJR Am J Roentgenol 4 Anticancer Res 4 Biochem Biophys Res Commun 4 BMC Cancer 1 Cancer Res 7 Dig Dis Sci 2 Endoscopy 2 Eur Radiol 2 Gastroenterology 2 Gastrointest Endosc 12 Hepatology 1 Indian J Gastroenterol 1 Int J Cancer 1 J Gastroenterol 2 J Gastroenterol Hepatol 18 J Hepatol 2 Lancet Gastroenterol Hepatol 2 Oncogene 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJR Am J Roentgenol

1. WANG L, Liu C, Liu J, Li P, et al
   MRI-Guided Cryoablation of Hepatic Dome Hepatocellular Carcinomas Using 1-T Open High-Field-Strength Scanner.
   AJR Am J Roentgenol. 2019 Mar 12:1-9. doi: 10.2214/AJR.18.19815.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

2. ORTEGA-GRANADOS AL, Artal-Cortes A, Aguiar-Bujanda D, Oramas J, et al
   Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer.
   Anticancer Res. 2019;39:1317-1328.
   PubMed     Text format     Abstract available
   
   
3. KEMPER M, Strohm T, Grupp K, Ghadban T, et al
   Increase of CD45-positive Immune Cells in Liver Parenchyma Indicates a More Favorable Prognosis for Patients With Barrett's Cancer.
   Anticancer Res. 2019;39:1191-1196.
   PubMed     Text format     Abstract available
   
   
4. YANO Y, Yoshimatsu K, Yokomizo H, Sagawa M, et al
   Enhancement of the Marginal Area in Colorectal Cancer Liver Metastasis on Computed Tomography Correlates With Microvessel Density and Clinicopathological Factors.
   Anticancer Res. 2019;39:1301-1308.
   PubMed     Text format     Abstract available
   
   
5. NISHIE A, Akahori S, Asayama Y, Ishigami K, et al
   Prediction of Liver Fibrosis Using CT Under Respiratory Control: New Attempt Using Deformation Vectors Obtained by Non-rigid Registration Technique.
   Anticancer Res. 2019;39:1417-1424.
   PubMed     Text format     Abstract available
   
   

   
   Biochem Biophys Res Commun

6. YANG Y, Lu Y, Han F, Chang Y, et al
   Saxagliptin regulates M1/M2 macrophage polarization via CaMKKbeta/AMPK pathway to attenuate NAFLD.
   Biochem Biophys Res Commun. 2018;503:1618-1624.
   PubMed     Text format     Abstract available
   
   
7. HU X, Tang Z, Ma S, Yu Y, et al
   Tripartite motif-containing protein 7 regulates hepatocellular carcinoma cell proliferation via the DUSP6/p38 pathway.
   Biochem Biophys Res Commun. 2019 Mar 5. pii: S0006-291X(19)30180.
   PubMed     Text format     Abstract available
   
   
8. HUANG H, Deng Z
   Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis.
   Biochem Biophys Res Commun. 2019 Mar 7. pii: S0006-291X(19)30362.
   PubMed     Text format     Abstract available
   
   
9. CHEN X, Wang K, Cederbaum AI, Lu Y, et al
   Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice.
   Biochem Biophys Res Commun. 2019 Mar 12. pii: S0006-291X(19)30392.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

10. SHA M, Jeong S, Wang X, Tong Y, et al
    Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma.
    BMC Cancer. 2019;19:208.
    PubMed     Text format     Abstract available
    
    
11. WEN Q, Xu C, Zhou J, Liu NM, et al
    8-bromo-7-methoxychrysin suppress stemness of SMMC-7721 cells induced by co-culture of liver cancer stem-like cells with hepatic stellate cells.
    BMC Cancer. 2019;19:224.
    PubMed     Text format     Abstract available
    
    
12. ZHENG BH, Liu LZ, Zhang ZZ, Shi JY, et al
    Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients.
    BMC Cancer. 2018;18:1148.
    PubMed     Text format     Abstract available
    
    
13. BI C, Liu M, Rong W, Wu F, et al
    High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study.
    BMC Cancer. 2019;19:213.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

14. TAKAI A, Dang H, Oishi N, Khatib S, et al
    Genome-wide RNAi Screen identifies PMPCB as a therapeutic vulnerability in EpCAM+ hepatocellular carcinoma.
    Cancer Res. 2019 Mar 12. pii: 0008-5472.CAN-18-3015.
    PubMed     Text format     Abstract available
    
    

    
    Dig Dis Sci

15. NORONHA FERREIRA C, Reis D, Cortez-Pinto H, Tato Marinho R, et al
    Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Dig Dis Sci. 2019 Mar 9. pii: 10.1007/s10620-019-05572.
    PubMed     Text format     Abstract available
    
    
16. SPOSITO C, Cucchetti A, Mazzaferro V
    Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Mar 9. pii: 10.1007/s10620-019-05538.
    PubMed     Text format     Abstract available
    
    
17. FUCHS M, Levy MF
    Introduction to the Emmet B. Keeffe, MD, Commemorative Special Issue on Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Mar 12. pii: 10.1007/s10620-019-05574.
    PubMed     Text format    
    
    
18. HIRODE G, Vittinghoff E, Wong RJ
    Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample.
    Dig Dis Sci. 2019 Mar 13. pii: 10.1007/s10620-019-05576.
    PubMed     Text format     Abstract available
    
    
19. WEI M, Ford J, Li Q, Jeong D, et al
    Correction to: Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
    Dig Dis Sci. 2019 Mar 13. pii: 10.1007/s10620-019-05558.
    PubMed     Text format     Abstract available
    
    
20. SONI PD, Palta M
    Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities.
    Dig Dis Sci. 2019 Mar 14. pii: 10.1007/s10620-019-05539.
    PubMed     Text format     Abstract available
    
    
21. LUO X, Liu Y, Ma S, Liu L, et al
    WDR34 Activates Wnt/Beta-Catenin Signaling in Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Mar 15. pii: 10.1007/s10620-019-05583.
    PubMed     Text format     Abstract available
    
    

    
    Endoscopy

22. LI H, Ye D, Kong D
    Endoscopic clipping prior to n-butyl-2-cyanoacrylate injection for gastric varices with a large gastrorenal shunt.
    Endoscopy. 2018;50:E102-E103.
    PubMed     Text format    
    
    
23. SHAH SL, Xu MM, Dawod E, Halazun K, et al
    A wormy surprise: ERCP for intrabiliary drainage of a hydatid cyst.
    Endoscopy. 2018;50:E81-E82.
    PubMed     Text format    
    
    

    
    Eur Radiol

24. QU Y, Li M, Hamilton G, Zhang YN, et al
    Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis.
    Eur Radiol. 2019 Mar 15. pii: 10.1007/s00330-019-06071.
    PubMed     Text format     Abstract available
    
    
25. SEO N, Kim MJ, Rhee H
    Hepatic sarcomatoid carcinoma: magnetic resonance imaging evaluation by using the liver imaging reporting and data system.
    Eur Radiol. 2019 Mar 11. pii: 10.1007/s00330-019-06052.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

26. MARQUARDT P, Hoshida Y, Singal AG
    Aspirin: Does it Have a Role for Chemoprevention of Hepatocellular Carcinoma?
    Gastroenterology. 2019 Mar 5. pii: S0016-5085(19)32516.
    PubMed     Text format    
    
    
27. HILSCHER MB, Sehrawat T, Arab Verdugo JP, Zeng Z, et al
    Mechanical Stretch Increases Expression of CXCL1 in Liver Sinusoidal Endothelial Cells to Recruit Neutrophils, Generate Sinusoidal Microthombi, and Promote Portal Hypertension.
    Gastroenterology. 2019 Mar 11. pii: S0016-5085(19)33554.
    PubMed     Text format     Abstract available
    
    

    
    Gastrointest Endosc

28. MOK SRS, Diehl DL, Johal AS, Khara HS, et al
    A prospective pilot comparison of wet and dry heparinized suction for EUS-guided liver biopsy (with videos).
    Gastrointest Endosc. 2018;88:919-925.
    PubMed     Text format     Abstract available
    
    
29. KOTHARI S, Li Y, Berkelhammer C, Almouradi T, et al
    Radiation gastritis after Yttrium-90 radioembolization.
    Gastrointest Endosc. 2018;88:965-966.
    PubMed     Text format    
    
    

    
    Hepatology

30. WANG YL, Liu JY, Yang JE, Yu XM, et al
    Lnc-UCID promotes G1/S transition and hepatoma growth by preventing DHX9-mediated CDK6 downregulation.
    Hepatology. 2019 Mar 13. doi: 10.1002/hep.30613.
    PubMed     Text format     Abstract available
    
    
31. NOH JH, Gorospe M
    AKTions by Cytoplasmic lncRNA CASC9 Promote Hepatocellular Carcinoma Survival.
    Hepatology. 2018;68:1675-1677.
    PubMed     Text format    
    
    
32. KORATALA A, Alquadan KF
    Diminishing Kidney Reserve and the "Pseudo"normal Creatinine.
    Hepatology. 2018;68:2045.
    PubMed     Text format    
    
    
33. KHADERI S, Sussman N, Kanwal F
    Project ECHO: The Specialist Will See You Now.
    Hepatology. 2018;68:2066-2068.
    PubMed     Text format    
    
    
34. BRENNER DA
    Of Mice and Men and Nonalcoholic Steatohepatitis.
    Hepatology. 2018;68:2059-2061.
    PubMed     Text format    
    
    
35. TARGHER G, Byrne CD
    Ad Libitum Mediterranean or Low-Fat Diets as Treatments for Nonalcoholic Fatty Liver Disease?
    Hepatology. 2018;68:1668-1671.
    PubMed     Text format    
    
    
36. MUZYKANTOV VR, Brenner JS
    Vascular Immunotargeting: Take the Highway to the First Exit.
    Hepatology. 2018;68:1672-1674.
    PubMed     Text format    
    
    
37. IMAI N, Cohen DE
    Trimming the Fat: Acetyl-CoA Carboxylase Inhibition for the Management of NAFLD.
    Hepatology. 2018;68:2062-2065.
    PubMed     Text format    
    
    
38. CARDOSO FS
    Acute-on-Chronic Liver Failure defined by NACSELD: The Impact on Prognosis and Futility of Care.
    Hepatology. 2018;68:2046.
    PubMed     Text format    
    
    
39. O'LEARY JG, Rajender Reddy K, Wong F, Garcia-Tsao G, et al
    Reply.
    Hepatology. 2018;68:2046-2048.
    PubMed     Text format    
    
    
40. VERMA S, Agarwal S, Singh S, Pandey N, et al
    Letter To Editor: Terlipressin is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute On Chronic Liver Failure.
    Hepatology. 2018;68:2442-2443.
    PubMed     Text format    
    
    
41. ARORA V, Sarin SK
    Reply.
    Hepatology. 2018;68:2444.
    PubMed     Text format    
    
    

    
    Indian J Gastroenterol

42. RAY G
    Long-term outcome of endoscopic variceal band ligation of esophageal varices in patients with chronic liver disease.
    Indian J Gastroenterol. 2019 Mar 14. pii: 10.1007/s12664-019-00938.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

43. BOYSEN AK, Spindler KL, Hoyer M, Mortensen FV, et al
    Metastasis directed therapy for liver and lung metastases from colorectal cancer - a population based study.
    Int J Cancer. 2018 Jun 19. doi: 10.1002/ijc.31626.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol

44. NAGANUMA A, Chayama K, Notsumata K, Gane E, et al
    Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infection.
    J Gastroenterol. 2019 Mar 13. pii: 10.1007/s00535-019-01569.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol Hepatol

45. YAMADA K, Mizukoshi E, Seike T, Horii R, et al
    Serum C16:1n7/C16:0 ratio as a diagnostic marker for non-alcoholic steatohepatitis Diagnosis of NASH using serum fatty acid.
    J Gastroenterol Hepatol. 2019 Mar 12. doi: 10.1111/jgh.14654.
    PubMed     Text format     Abstract available
    
    
46. ZENG X, Li XX, Shi PM, Zhang YY, et al
    Utility of the EncephalApp Stroop Test for Covert Hepatic Encephalopathy Screening in Chinese Cirrhotic Patients.
    J Gastroenterol Hepatol. 2019 Mar 12. doi: 10.1111/jgh.14656.
    PubMed     Text format     Abstract available
    
    

    
    J Hepatol

47. GALAND J, Ley D, Coopman S, Michaud L, et al
    Primary prophylaxis of oesophageal variceal bleeding in children by ligation is safe and as efficient as secondary prophylaxis.
    J Hepatol. 2018;68:600-601.
    PubMed     Text format    
    
    
48. NAGATA H, Nakagawa M, Asahina Y
    Reply to: "Imaging Basis of AFP and WFA(+)M2BP as Indicators of the risk of HCC after SVR".
    J Hepatol. 2018;68:607-608.
    PubMed     Text format    
    
    
49. MAZZEO AT, Maimone S
    Acid-base disorders in liver disease.
    J Hepatol. 2018;68:617-618.
    PubMed     Text format    
    
    
50. SCHEINER B, Funk GC
    Reply to: "Acid-base disorders in liver disease".
    J Hepatol. 2018;68:618-619.
    PubMed     Text format    
    
    
51. WAZIRY R, Amin J, Law M, Dore GJ, et al
    Reply to: "Direct antiviral agents and risk of HCC: Waiting for Godot".
    J Hepatol. 2018;68:616-617.
    PubMed     Text format    
    
    
52. WANG XC, Zhang XY, Zhang X, Yuan ZX, et al
    Pitfalls in the non-invasive assessment of liver fibrosis with eLIFT-FM(VCTE) algorithm.
    J Hepatol. 2018;68:602-603.
    PubMed     Text format    
    
    
53. PETIT JM, Bouillet B, Loffroy R, Rouland A, et al
    Application of the new eLIFT test for the non-invasive diagnosis of advanced liver fibrosis in people with type 2 diabetes.
    J Hepatol. 2018;68:603-604.
    PubMed     Text format    
    
    
54. BOURSIER J, de Ledinghen V, Leroy V, Cales P, et al
    Reply to: "Pitfalls in the non-invasive assessment of liver fibrosis with eLIFT-FM(VCTE) algorithm" and to "Application of the new eLIFT test for the non-invasive diagnosis of advanced liver fibrosis in people with type 2 diabetes".
    J Hepatol. 2018;68:605-606.
    PubMed     Text format    
    
    
55. XU X, Zhang HL, Liu QP, Sun SW, et al
    Radiomic Analysis of Contrast-Enhanced CT Predicts Microvascular Invasion and Outcome in Hepatocellular Carcinoma.
    J Hepatol. 2019 Mar 12. pii: S0168-8278(19)30145.
    PubMed     Text format     Abstract available
    
    
56. ARTRU F, Louvet A
    Reply to <<Liver transplantation for grade 3 acute-on-chronic liver failure: type of organ failure is important>>.
    J Hepatol. 2017 Oct 31. pii: S0168-8278(17)32402.
    PubMed     Text format    
    
    
57. CHOUDHARY NS, Saraf N, Soin AS
    Liver Transplantation for Grade 3 Acute on Chronic Liver Failure: Type of Organ Failure is Important.
    J Hepatol. 2017 Oct 31. pii: S0168-8278(17)32401.
    PubMed     Text format    
    
    
58. BEIER JI, Banales JM
    Pyroptosis: An inflammatory link between NAFLD and NASH with potential therapeutic implications.
    J Hepatol. 2018;68:643-645.
    PubMed     Text format    
    
    
59. LOUVET A, Krag A
    Managing excessive alcohol consumption at a population level: The earlier the better.
    J Hepatol. 2018;68:389-390.
    PubMed     Text format    
    
    
60. LEE S, Kim SH
    Reply to: "Detecting microvascular invasion in HCC with contrast-enhanced MRI: Is it a good idea?"
    J Hepatol. 2018;68:863-864.
    PubMed     Text format    
    
    
61. HUO TI, Liu PH, Hsu CY
    Detecting microvascular invasion in HCC with contrast-enhanced MRI: Is it a good idea?
    J Hepatol. 2018;68:862-863.
    PubMed     Text format    
    
    
62. ATKINSON SR, Way MJ, McQuillin A, Morgan MY, et al
    Reply to: "The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population-based cohort".
    J Hepatol. 2018;68:860-862.
    PubMed     Text format    
    
    
63. BYRNE CD, Perseghin G
    Non-alcoholic fatty liver disease: A risk factor for myocardial dysfunction?
    J Hepatol. 2018;68:640-642.
    PubMed     Text format    
    
    
64. MENDIZABAL M, Silva M
    Acute liver failure: Do the EASL guidelines address the whole spectrum?
    J Hepatol. 2018;68:843.
    PubMed     Text format    
    
    

    
    Lancet Gastroenterol Hepatol

65. CARBONE M, Nardi A, Flack S, Carpino G, et al
    Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.
    Lancet Gastroenterol Hepatol. 2018 Jul 12. pii: S2468-1253(18)30163.
    PubMed     Text format     Abstract available
    
    
66. 
    Correction to Lancet Gastroenterol Hepatol 2019; 4: 208-16.
    Lancet Gastroenterol Hepatol. 2019;4:e3.
    PubMed     Text format    
    
    

    
    Oncogene

67. YANG H, Zhu R, Zhao X, Liu L, et al
    Sirtuin-mediated deacetylation of hnRNP A1 suppresses glycolysis and growth in hepatocellular carcinoma.
    Oncogene. 2019 Mar 11. pii: 10.1038/s41388-019-0764.
    PubMed     Text format     Abstract available
    
    
68. ZHANG H, Song Y, Yang H, Liu Z, et al
    Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-kappaB/IL-6/STAT3 axis.
    Oncogene. 2018;37:2456-2468.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

69. SU L, Chang L, Sun Q, Hu L, et al
    Effects of low-dose energy spectrum scanning combined with adaptive statistical iterative reconstruction on the quality of imaging in Budd-Chiari syndrome.
    PLoS One. 2018;13:e0204797.
    PubMed     Text format     Abstract available
    
    
70. TORAIH EA, Alghamdi SA, El-Wazir A, Hosny MM, et al
    Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors.
    PLoS One. 2018;13:e0198231.
    PubMed     Text format     Abstract available
    
    
71. GHOBRIAL C, Mogahed EA, El-Karaksy H
    Routine analysis of ascitic fluid for evidence of infection in children with chronic liver disease: Is it mandatory?
    PLoS One. 2018;13:e0203808.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: